BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chou R, Dana T, Fu R, Zakher B, Wagner J, Ramirez S, Grusing S, Jou JH. Screening for Hepatitis C Virus Infection in Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2020;Epub ahead of print. [PMID: 32119034 DOI: 10.1001/jama.2019.20788] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Eames JR, Tran B. Hepatitis C. Physician Assistant Clinics 2021;6:555-68. [DOI: 10.1016/j.cpha.2021.05.002] [Reference Citation Analysis]
2 Gatta LA, Hughes BL. Premature Rupture of Membranes with Concurrent Viral Infection. Obstet Gynecol Clin North Am 2020;47:605-23. [PMID: 33121648 DOI: 10.1016/j.ogc.2020.08.006] [Reference Citation Analysis]
3 Zucker J, Purpura L, Sani F, Huang S, Schluger A, Ruperto K, Slowkowski J, Olender S, Scherer M, Castor D, Gordon P. Individualized Provider Feedback Increased HIV and HCV Screening and Identification in a New York City Emergency Department. AIDS Patient Care STDS 2022;36:106-14. [PMID: 35289689 DOI: 10.1089/apc.2021.0225] [Reference Citation Analysis]
4 Denis CM, Dominique T, Smith P, Fiore D, Ku YC, Culhane A, Dunbar D, Brown D, Daramay M, Voytek C, Morales KH, Blank MB, Crits-Christoph PF, Douglas SD, Spitsin S, Frank I, Colon-Rivera K, Montaner LJ, Metzger DS, Evans DL. HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic. AIDS Behav 2021;25:2230-9. [PMID: 33449236 DOI: 10.1007/s10461-020-03151-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Garrido I, Macedo G. Letter: universal screening for hepatitis C in pregnant women, children and adolescents. Aliment Pharmacol Ther 2021;54:977-8. [PMID: 34506663 DOI: 10.1111/apt.16546] [Reference Citation Analysis]
6 Fimmel CJ, Khan MQ, Belopolsky Y, Imas P, Gampa A, Sonnenberg A. Sustained and cumulative impact of an electronic medical record-based alert on a hepatitis C birth cohort screening programme. J Viral Hepat 2021;28:1200-5. [PMID: 33896092 DOI: 10.1111/jvh.13524] [Reference Citation Analysis]
7 Javanbakht M, Archer R, Klausner J. Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system. PLoS One 2020;15:e0241615. [PMID: 33147293 DOI: 10.1371/journal.pone.0241615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Girardin F, Painter C, Hearmon N, Eddowes L, Kaiser S, Negro F, Vernaz N. Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy. JHEP Rep 2021;3:100279. [PMID: 34522875 DOI: 10.1016/j.jhepr.2021.100279] [Reference Citation Analysis]
9 Jager J, Keyes KM, Son D, Kloska D, Patrick ME, Schulenberg JE. Cohort and age trends in age 35-45 prevalence of alcohol use disorder symptomology, by severity, sex, race, and education. Drug Alcohol Depend 2021;226:108820. [PMID: 34245999 DOI: 10.1016/j.drugalcdep.2021.108820] [Reference Citation Analysis]
10 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7-33. [PMID: 33433946 DOI: 10.3322/caac.21654] [Cited by in Crossref: 809] [Cited by in F6Publishing: 980] [Article Influence: 809.0] [Reference Citation Analysis]
11 Alkrekshi A, Kassem A, Park C, Tse W. Risk of Non-Hodgkin's Lymphoma in HCV Patients in the United States Between 2013 and 2020: A Population-Based Study. Clin Lymphoma Myeloma Leuk 2021:S2152-2650(21)00244-5. [PMID: 34330674 DOI: 10.1016/j.clml.2021.06.014] [Reference Citation Analysis]
12 Rogers ME, Balistreri WF. Cascade of care for children and adolescents with chronic hepatitis C. World J Gastroenterol 2021; 27(12): 1117-1131 [PMID: 33828389 DOI: 10.3748/wjg.v27.i12.1117] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
13 Fadnes LT, Aas CF, Vold JH, Leiva RA, Ohldieck C, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA; INTRO-HCV Study Group. Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). PLoS Med 2021;18:e1003653. [PMID: 34061883 DOI: 10.1371/journal.pmed.1003653] [Reference Citation Analysis]
14 Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372:n160. [PMID: 33781993 DOI: 10.1136/bmj.n160] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 79.0] [Reference Citation Analysis]
15 Xia H, Zhang Y, Zaongo SD, Liang J, Gong X, Hu Y, Ma P, Wang F. Direct-acting antiviral treatments display excellent outcomes even in older HCV-infected patients at increased risk of fibrosis. Ann Transl Med 2021;9:847. [PMID: 34164481 DOI: 10.21037/atm-21-1297] [Reference Citation Analysis]
16 Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB; US Preventive Services Task Force. Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA 2020;324:2415-22. [PMID: 33320230 DOI: 10.1001/jama.2020.22980] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
17 Whitman TJ, Noyes CD, Hale AJ, Singh D, DeVoe SG, Repp AB, Pierce KK, Polish LB, Kirkpatrick BD, Dejace J, Smith LM, Lahey T, Huston CD, Catoe LJ, Ghatage P, Bullis S, Alston WK. Impact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centre. BMJ Open Qual 2021;10:e001248. [PMID: 33593729 DOI: 10.1136/bmjoq-2020-001248] [Reference Citation Analysis]
18 Indolfi G, Kelly D, Nebbia G, Iorio R, Mania A, Giacomet V, Szenborn L, Shao J, Sang Yue M, Hsueh CH, Parhy B, Kersey K, Mangia A, Pawlowska M, Bansal S. Sofosbuvir-velpatasvir-voxilaprevir in adolescents 12 to 17 years old with HCV infection. Hepatology 2022. [PMID: 35112372 DOI: 10.1002/hep.32393] [Reference Citation Analysis]
19 Mendizabal M, Piñero F, Ridruejo E. Reply. Clin Gastroenterol Hepatol 2021;19:623-4. [PMID: 33248093 DOI: 10.1016/j.cgh.2020.05.043] [Reference Citation Analysis]
20 Litaker JR, Tamez N, Lopez Bray C, Allison RD, Durkalski W, Taylor R. Hepatitis C Antibody Screening Among Baby Boomers by a Community-Based Health Insurance Company. Popul Health Manag 2021;24:492-5. [PMID: 33197366 DOI: 10.1089/pop.2020.0214] [Reference Citation Analysis]
21 Rosenberg ES, Barocas JA. USPSTF's Hepatitis C Screening Recommendation-A Necessary Step to Tackling an Evolving Epidemic. JAMA Netw Open 2020;3:e200538. [PMID: 32119098 DOI: 10.1001/jamanetworkopen.2020.0538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
22 Yadav SR, Goldman DA, Murray KF. Hepatitis C: Current State of Treatment in Children. Pediatr Clin North Am 2021;68:1321-31. [PMID: 34736592 DOI: 10.1016/j.pcl.2021.07.008] [Reference Citation Analysis]